KRAS and neoplasm: Bioengineered exosomes loaded with siRNAs targeting genes involved in oncogenes like BCL-2, PLK1, KRAS, the survivin protein prevents cell migration and proliferation and forms a strong foundation of exosome mediated siRNA treatment to the tumor cells.